Jonathan Sung

Jonathan Sung practices at Internal Medicine and Nephrology Med. Group Inc. in Torrance, California.

Jonathan Sung's NPI, 1477057859, was assigned on March 21, 2018. Jonathan Sung graduated from St. George's University School of Medicine in 2018. Jonathan Sung's California license number on file is A173433.

Jonathan Sung's primary practice is Internal Medicine and Nephrology Med. Group Inc., at 3291 Skypark Dr, Torrance, CA 90505 in Los Angeles County. The practice phone is (310) 325-4517.

Jonathan Sung's primary practice is Internal Medicine and Nephrology Med. Group Inc. in Torrance, California. Jonathan Sung is also affiliated with Torrance Memorial Medical Center. The medical group on file is Internal Medicine & Nephrology Medical Group, Inc. Dmand AI also links Jonathan Sung to 2 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Sung practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Jonathan Sung's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Jonathan Sung is board certified in internal medicine by the American Board of Internal Medicine. Jonathan Sung has a license on file in California.

Dmand AI lists acute kidney failure, chronic diabetes and chronic kidney disease among the conditions Jonathan Sung treats.

CMS data shows 1,323 Medicare services from Jonathan Sung across 7 procedure codes in 2024, for 383 Medicare patients. Medicare paid $116,157 for them.

CMS counts 383 Medicare patients who saw Jonathan Sung in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 3.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Sung's median patient age at 72, with 51% women.

In 2024, Jonathan Sung wrote 713 Medicare Part D claims for 144 patients. 62% of them were for generic drugs. CMS names the drug for 499 of them, across 18 drugs with 11 or more claims each, at $213,110 in total drug cost. In 2023, CMS named 247 claims across 11 drugs.

Jonathan Sung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jonathan Sung as offering telehealth.

Dmand AI links 13 papers to Jonathan Sung, published from 2011 to 2023. 2022 was the busiest year, with 5. The most frequent topics are Percutaneous Coronary Intervention and Electrocardiography. Jonathan Sung has published most often in Am J Cardiol. Jonathan Sung's most frequent co-authors are Abhishek Chaturvedi, MD, Nihar Desai, MD, MPH and Avirup Guha, MBBS.

CMS Open Payments shows 270 general payments to Jonathan Sung from 36 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 99% of the total. Aurinia Pharma U.S., Inc. paid the most, $814.

Jonathan Sung graduated from St. George's University School of Medicine in 2018.

Jonathan Sung is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.